André Malanda

Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.

M. Castel, P. Barnéoud, T. Rooney, 2019, Bioorganic & medicinal chemistry letters.

Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC.

N. Andersen, C. Raetz, A. Erwin, 2002, Journal of medicinal chemistry.

Data on synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel NURR1/NOT agonist potentially useful for the treatment of Parkinson's disease

P. Barnéoud, D. Lesuisse, X. Vigé, 2019, Data in brief.